2026 Mark Boguniewicz: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	83	1416	1292	722	645	349	33486

Overview

Mark Boguniewicz is affiliated with National Jewish Health in the United States and has an extensive research portfolio in the field of medicine, with a particular focus on dermatology and immunology.

Their work primarily spans several subfields of study, including:

Dermatology
Immunology and Allergy
Physiology
Rheumatology
Immunology

The main topics covered in their research include:

Dermatology and Skin Diseases
Allergic Rhinitis and Sensitization
Asthma and Respiratory Diseases
Food Allergy and Anaphylaxis Research
Urticaria and Related Conditions
IL-33, ST2, and ILC Pathways
Transgenic Plants and Applications

Frequent publication venues for Boguniewicz's work are:

Journal of Allergy and Clinical Immunology
Annals of Allergy Asthma & Immunology
British Journal of Dermatology
Journal of the American Academy of Dermatology
The Journal of Allergy and Clinical Immunology In Practice

Among the recent papers associated with Boguniewicz are:

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial (2020) - Journal of the American Academy of Dermatology
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations (2023) - Annals of Allergy Asthma & Immunology
The infectious complications of atopic dermatitis (2020) - Annals of Allergy Asthma & Immunology
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials (2023) - Journal of Allergy and Clinical Immunology
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis (2022) - Allergy

Frequent co-authors collaborating with Boguniewicz include:

Jonathan I. Silverberg
Eric L. Simpson
Peck Y. Ong
Anna De Benedetto
Lisa A. Beck

Best Publications

Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis

Peck Y. Ong;Takaaki Ohtake;Corinne Brandt;Ian Strickland

2560
Citations
New insights into atopic dermatitis

Donald Y.M. Leung;Mark Boguniewicz;Michael D. Howell;Ichiro Nomura

2026
Citations
Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation

Mark Boguniewicz;Donald Y. M. Leung

1382
Citations
Cytokine modulation of atopic dermatitis filaggrin skin expression

Michael D. Howell;Byung Eui Kim;Peisong Gao;Audrey V. Grant

1372
Citations
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

Qutayba Hamid;Mark Boguniewicz;Donald Y. M. Leung

1054
Citations
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

C A Akdis;M Akdis;T Bieber;C Bindslev-Jensen

1025
Citations
Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes

Ichiro Nomura;Elena Goleva;Michael D. Howell;Quatyba A. Hamid

945
Citations
Tight junction defects in patients with atopic dermatitis.

Anna De Benedetto;Nicholas M. Rafaels;Laura Y. McGirt;Andrei I. Ivanov

844
Citations
Loricrin and Involucrin Expression is Down-Regulated by Th2 Cytokines through STAT-6

B.E. Kim;D.Y.M. Leung;M. Boguniewicz;M.D. Howell

692
Citations
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Amy S. Paller;Wynnis L. Tom;Wynnis L. Tom;Mark G. Lebwohl;Robin L. Blumenthal

632
Citations
Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study

Jonathan I. Silverberg;Joel M. Gelfand;David J. Margolis;Mark Boguniewicz

619
Citations
In vivo expression of IL-12 and IL-13 in atopic dermatitis

Qutayba Hamid;Tanveer Naseer;Eleanor M. Minshall;Yan L. Song

582
Citations
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.

Janine Bilsborough;Donald Y.M. Leung;Mark Maurer;Michael Howell

570
Citations
Atopic dermatitis: A practice parameter update 2012

Lynda Schneider;Stephen Tilles;Peter Lio;Mark Boguniewicz

543
Citations
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

Eric L. Simpson;Amy S. Paller;Elaine C. Siegfried;Mark Boguniewicz

528
Citations
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Lawrence F. Eichenfield;Anne W. Lucky;Mark Boguniewiczc;Richard G.B. Langley

475
Citations
Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus

Michael D. Howell;Richard L. Gallo;Mark Boguniewicz;James F. Jones

446
Citations
Recent insights into atopic dermatitis and implications for management of infectious complications.

Mark Boguniewicz;Donald Y.M. Leung

431
Citations
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions

Masao Toda;Donald Y.M. Leung;Sophie Molet;Mark Boguniewicz

429
Citations
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children

Mark Boguniewicz;Virginia C. Fiedler;Sharon Raimer;Ira D. Lawrence

421
Citations
Cytokine modulation of atopic dermatitis filaggrin skin expression.

Unknown

368
Citations

Frequent Co-Authors

Donald Y.M. Leung National Jewish Health

Eric L. Simpson Oregon Health & Science University

Lisa A. Beck University of Rochester Medical Center

Lynda C. Schneider Boston Children's Hospital

Jon M. Hanifin Oregon Health & Science University

Jonathan I. Silverberg George Washington University Hospital

David J. Margolis University of Pennsylvania

Lawrence F. Eichenfield University of California, San Diego

Joel M. Gelfand University of Pennsylvania

Amy S. Paller Northwestern University

External Links

Personal website of Mark Boguniewicz

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied healthcare fields can broaden career opportunities. Nursing, for example, offers a solid foundation in patient care and biomedical sciences, which complements immunology knowledge well. Many start with accelerated programs designed for career changers or non-nurses, such as online BSN programs for non nurses.

If you're looking for accessible entry points into nursing, some of the easiest ABSN programs to get into offer flexible formats and streamlined admissions. These programs help fast-track your education and can be a stepping stone toward advanced practice.

Licensed Practical Nurse (LPN) programs also present options for quicker entry into healthcare. Identifying which LPN programs are easiest to get into allows students to find programs that fit their schedule and get practical experience in patient care.

For those pursuing higher levels of specialization, nurse practitioner degrees provide advanced clinical skills and leadership opportunities. Exploring the easiest nurse practitioner program options can guide you to programs that balance quality education with accessible entry requirements.